20 May 2024
Cancers | Highly Cited Special Issues in 2022–2023 related to Cancer Immunology and Immunotherapy
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to invite you to read the highly cited Special Issues in 2022 and 2023 related to cancer immunology and immunotherapy in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant Special issue can be seen below.
|
|
|
|
“Advances in Cancer Immunotherapy” Guest Editor: Dr. Daniela Montagna |
“Cancer Immunotherapy and Immune-Related Adverse Events” Guest Editor: Dr. Shaheen Khan |
|
|
|
|
“Immune Microenvironment and Cancer Progression” Guest Editor: Dr. Esteban Orenes-Piñero |
“Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?” Guest Editor: Dr. Constantin N. Baxevanis |
|
|
|
|
“Immunohistochemical Markers in Endometrial Cancer” Guest Editors: Prof. Dr. Valerio Mais and Dr. Michele Peiretti |
“Prostate-Specific Membrane Antigen (PSMA)” Guest Editor: Prof. Kambiz Rahbar |
|
|
|
|
“Inflammation and the Immunosuppressive Pancreatic Cancer Microenvironment” Guest Editor: Dr. Brian A. Boone and Dr. Tim D. Eubank |
“Engineering the Tumor Immune Microenvironment” Guest Editor: Dr. Scott S. Verbridge |
You are invited to view and submit relevant papers, proposals for some related special issues to the journal Cancers at the following links:
Cancers Editorial Office